ADRB2 and serum lipopolysaccharide activity: It was shown that, in experimental models of infection like sepsis, β2-AR antagonist administration increases susceptibility to LPS-induced endotoxemia (Grailer et al., 2014) and ADRB2 knockout animals were highly susceptible to LPS-mediated endotoxemia (Ağaç et al., 2018).